Cite
HARVARD Citation
Geisshüsler, S. et al. (2022). Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses. Advanced nanobiomed research. 2 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Geisshüsler, S. et al. (2022). Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses. Advanced nanobiomed research. 2 (4), p. n/a. [Online].